By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


3SBio Inc. 

3 A1, Road 10
Economy & Technology Development Zone
Shenyang    110027  China
Phone: 86-24-2581-1820 Fax:


Company News
Week In Review: 3SBio Inc. (SSRX) Snags Global Rights To mAb For Arthritis 6/29/2015 9:43:19 AM
3SBio Inc. (SSRX) Acquires Global Rights to Bay Area Apexigen’s Anti-TNF mAb 6/22/2015 7:15:01 AM
Week In Review: 3SBio Inc. (SSRX) Rises 5% After $711 Million IPO 6/15/2015 9:10:26 AM
3SBio Inc. (SSRX) Climbs 5% In First Trading Day In Hong Kong 6/11/2015 2:12:56 PM
Week In Review: 3SBio Inc. (SSRX) To Stage $712 Million Hong Kong IPO 6/1/2015 9:55:57 AM
3SBio Inc. (SSRX) Sets Target Of $712 Million For Hong Kong IPO 5/28/2015 8:45:33 AM
3SBio Inc. (SSRX) Files for Hong Kong IPO; May Raise Up To $500 Million 2/20/2015 10:53:59 AM
3SBio Inc. (SSRX) Acquires Sirton Pharmaceuticals SpA 1/26/2015 8:25:04 AM
3SBio Inc. (SSRX) Signs Exclusive Patent License Agreement For DIG-KT, A Bi-Specific mAb Targeting VEGFR2 And Tie-2 With Pharmabcine 1/15/2015 9:54:09 AM
3SBio Inc. (SSRX) Obtains Exclusive Licenses To Develop And Market Jenkem's PEG-Irinotecan In China 9/17/2014 8:10:42 AM